Display options
Cite
Linos E, Chren MM. Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma. JAMA Intern Med. 2021;181(8):1032-1033doi: 10.1001/jamainternmed.2021.2643.
Linos, E., & Chren, M. M. (2021). Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma. JAMA internal medicine, 181(8), 1032-1033. https://doi.org/10.1001/jamainternmed.2021.2643
Linos, Eleni, and Chren, Mary-Margaret. "Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma." JAMA internal medicine vol. 181,8 (2021): 1032-1033. doi: https://doi.org/10.1001/jamainternmed.2021.2643
Linos E, Chren MM. Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma. JAMA Intern Med. 2021 Aug 01;181(8):1032-1033. doi: 10.1001/jamainternmed.2021.2643. PMID: 34125141.
Copy Download .nbib Format: NLM
Share it on

JAMA Intern Med. 2021 Aug 01;181(8):1032-1033. doi: 10.1001/jamainternmed.2021.2643.

Active Surveillance as a Management Option for Low-risk Basal Cell Carcinoma.

JAMA internal medicine

Eleni Linos, Mary-Margaret Chren

Affiliations

  1. Department of Dermatology, Stanford University, Stanford, California.
  2. Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.

PMID: 34125141 DOI: 10.1001/jamainternmed.2021.2643

[No abstract available.]

Publication Types

Grant support